New scientific methods could one day render animal studies—the standard in research laboratories for more than 100 ...

HOUSTON--(BUSINESS WIRE)--IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new muscle with full length dystrophin in Becker ...

Now we're in a very exciting era where we can make, from a skin cell or a blood cell, your own, personalized, induced pluripotent (iPS) stem cell lines. We can differentiate those, potentially, into ...

A novel iPSC-derived lung-on-chip model mimics human alveolar tissue, revealing macrophage-driven tuberculosis responses.

If stem cell therapies are to reach patients with diabetes, Alzheimer's, sickle cell and other diseases, the infrastructure for delivering those must be planned and not left to wander, said the ...

Clonell launches the world’s first patient-specific embryonic stem cell therapy platform, aimed at incurable diseases with ...